½ÃÀ庸°í¼­
»óǰÄÚµå
1762558

¼¼°èÀÇ DNA Á¦Á¶ ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¾÷°è ºÐ¼®(À¯Çüº°, µî±Þº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°), ¿¹Ãø(2025-2034³â)

DNA Manufacturing Market Size, Share, Trends, & Industry Analysis Report By Type (Plasmid DNA, Synthetic DNA), By Grade, By Application, End Use, By Region - Market Forecast, 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 129 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, DNA Á¦Á¶ ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 218¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

ÇÕ¼º»ý¹°ÇÐ ¶Ç´Â À¯ÀüÀÚ ÇÕ¼ºÀ¸·Îµµ ¾Ë·ÁÁø DNA Á¦Á¶´Â ½ÇÇè½Ç¿¡¼­ DNA ºÐÀÚ¸¦ ÀÎÀ§ÀûÀ¸·Î ¸¸µé¾î³»´Â °úÁ¤ÀÔ´Ï´Ù. °úÇÐÀÚµéÀº ÷´Ü ±â¼úÀ» Ȱ¿ëÇÏ¿© ¸ÂÃãÇü DNA ¿°±â¼­¿­À» ¼³°èÇϰí Á¶¸³ÇÏ¿© ÀÚ¿¬¿¡ Á¸ÀçÇÏÁö ¾Ê´Â À¯Àü ¹°ÁúÀ» ¸¸µé°Å³ª ¿¬±¸ ¸ñÀûÀ¸·Î ±âÁ¸ ¿°±â¼­¿­À» º¹Á¦ÇÒ ¼ö ÀÖÀ¸¸ç, DNA Á¦Á¶´Â »ý¹°ÇÐ, È­ÇÐ, °øÇÐÀ» °áÇÕÇÏ¿© Á¤È®ÇÑ À¯ÀüÀÚ ±¸Á¶¹°À» ±¸ÃàÇÏ¿© ÀÇ·á, ³ó¾÷, »ý¸í°øÇÐ ºÐ¾ßÀÇ ±â¼ú Çõ½ÅÀÇ ±æÀ» ¿­¾îÁÝ´Ï´Ù. ÀÇ·á, ³ó¾÷, »ý¸í°øÇÐ ºÐ¾ßÀÇ ±â¼ú Çõ½ÅÀÇ ±æÀ» ¿­¾îÁÖ´Â °ÍÀÔ´Ï´Ù.

DNA Á¦Á¶ÀÇ ÁÖ¿ä ¿ëµµ Áß Çϳª´Â ÀÇÇÐ ¿¬±¸¿Í ÀǾàǰ °³¹ßÀÔ´Ï´Ù. °úÇÐÀÚµéÀº À¯ÀüÀÚ¸¦ ÇÕ¼ºÇÏ¿© Áúº´À» ¿¬±¸Çϰí, ¹é½ÅÀ» ¸¸µé°í, À¯ÀüÀÚ Ä¡·á¹ýÀ» °³¹ßÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ÇÕ¼º DNA´Â ¸é¿ª ¹ÝÀÀ¿¡ ´ëÇÑ À¯ÀüÀû û»çÁøÀ» Á¦°øÇÔÀ¸·Î½á Äڷγª19¿¡ »ç¿ëµÇ´Â °Í°ú °°Àº mRNA ¹é½Å°ú Ä¡·áÁ¦¸¦ Á¦Á¶ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿¬±¸ÀÚµéÀº ÇÕ¼º DNA¸¦ ÀÌ¿ëÇÑ ¹Ì»ý¹°À» °³¹ßÇÏ¿© Àν¶¸°, Ç×ü ¹× ±âŸ »ý¸íÀ» ±¸ÇÏ´Â »ý¹°ÇÐÀû Á¦Á¦¸¦ ±âÁ¸ ¹æ¹ýº¸´Ù ´õ È¿À²ÀûÀ¸·Î »ý»êÇϰí ÀÖ½À´Ï´Ù.

DNA Á¦Á¶¸¦ ÅëÇØ °úÇÐÀÚµéÀº Èñ±Í À¯Àü¼º Áúȯ¿¡ ´ëÇÑ À¯ÀüÀÚ Ä¡·á, ƯÁ¤ µ¹¿¬º¯À̸¦ Ç¥ÀûÀ¸·Î ÇÏ´Â ¾Ï ¸é¿ª ¿ä¹ý µî ¸ÂÃãÇü À¯ÀüÀÚ ¼­¿­À» ¼³°èÇÏ¿© ¸ÂÃãÇü Ä¡·á¹ýÀ» °³¹ßÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

DNA Á¦Á¶ ½ÃÀå : ºÐ¼® °³¿ä

À¯Çüº°·Î´Â ÇÕ¼º DNA ºÎ¹®ÀÌ Ä¡·áÁ¦, Áø´Ü, ÇÕ¼º »ý¹°Çп¡ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ¾î 2024³â¿¡´Â ÇÕ¼º DNA ºÎ¹®ÀÌ ÁÖ¿ä ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

µî±Þº°·Î´Â À¯ÀüÀÚ Ä¡·á, ¼¼Æ÷ Ä¡·á, DNA ±â¹Ý ¹é½Å°ú °°Àº ÷´Ü Ä¡·á ¿ëµµ¿¡ »ç¿ëµÇ´Â ÀÓ»ó µî±Þ DNA¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó GMP µî±Þ ºÎ¹®ÀÌ 2024³â Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¿ëµµº°·Î´Â ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ºÐ¾ß°¡ 2024³â ¸ÅÃâ ½ÃÀå Á¡À¯À²À» ÁÖµµÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§´Â ÷´Ü Ä¡·á Ç÷§ÆûÀÇ ÀÓ»ó ¹× »ó¾÷Àû Ȱµ¿ÀÇ ±Þ¼ÓÇÑ È®Àå¿¡ ±âÀÎÇÕ´Ï´Ù.

CRO(ÀÓ»ó½ÃÇè¼öʱâ°ü) ºÎ¹®Àº ÇâÈÄ ¸î ³â°£ °ßÁ¶ÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CRO´Â Àü¹®ÀûÀÎ Àü¹®¼º, È®Àå °¡´ÉÇÑ Á¦Á¶, ½Å¼ÓÇÑ ³³±â µîÀ» ÅëÇØ ÀǾàǰ °³¹ß¿¡ ÇʼöÀûÀÎ ÆÄÆ®³Ê·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì DNA Á¦Á¶ ½ÃÀåÀº 2024³â ¼¼°è ¸ÅÃâ Á¡À¯À²ÀÇ 47.38%¸¦ Â÷ÁöÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§´Â »ý¸í°øÇÐ, Á¦¾à, ÇÕ¼º»ý¹°ÇÐÀÇ ¹ßÀüÀ¸·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ DNA Á¦Á¶ »ê¾÷Àº ¹ÙÀÌ¿À Á¦¾à ºÐ¾ßÀÇ È®´ë, R&D ÅõÀÚ Áõ°¡, À¯ÀüüÇп¡ ´ëÇÑ Á¤ºÎ Áö¿øÀ¸·Î ÀÎÇØ ÇâÈÄ ¸î ³â µ¿¾È °ßÁ¶ÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ÁÖ¿ä ±â¾÷À¸·Î´Â Catalent, Charles River Laboratories, Danaher, Elegen, Eurofins Genomics, GenScript, Kaneka, Lonza, Probiotech, Thermo Fisher Scientific, Touchlite, VGXI, Wuxi AppTec µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ºÐ¼® ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ DNA Á¦Á¶ ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ÇöȲ
  • DNA Á¦Á¶ ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
  • PESTLE ºÐ¼®
  • DNA Á¦Á¶ ½ÃÀå µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ DNA Á¦Á¶ ½ÃÀå : À¯Çüº°

  • ÁÖ¿ä ºÐ¼® °á°ú
  • ¼­·Ð
  • Çö󽺹̵å DNA
  • ÇÕ¼º DNA

Á¦6Àå ¼¼°èÀÇ DNA Á¦Á¶ ½ÃÀå : µî±Þº°

  • ÁÖ¿ä ºÐ¼® °á°ú
  • ¼­·Ð
  • GMP µî±Þ
  • R&D µî±Þ

Á¦7Àå ¼¼°èÀÇ DNA Á¦Á¶ ½ÃÀå : ¿ëµµº°

  • ÁÖ¿ä ºÐ¼® °á°ú
  • ¼­·Ð
  • ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á
  • ¹é½Å
  • ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå°è ÀǾàǰ
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ DNA Á¦Á¶ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ÁÖ¿ä ºÐ¼® °á°ú
  • ¼­·Ð
  • Á¦¾à : ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • Çмú¿¬±¸±â°ü
  • CRO(ÀǾàǰ ÀÓ»ó½ÃÇè¼öʱâ°ü)

Á¦9Àå ¼¼°èÀÇ DNA Á¦Á¶ ½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä ºÐ¼® °á°ú
  • ¼­·Ð
    • DNA Á¦Á¶ ½ÃÀå ºÐ¼® : Áö¿ªº°(2020-2034³â)
  • ºÏ¹Ì
    • ºÏ¹Ì : À¯Çüº°(2020-2034³â)
    • ºÏ¹Ì : µî±Þº°(2020-2034³â)
    • ºÏ¹Ì : ¿ëµµº°(2020-2034³â)
    • ºÏ¹Ì : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ : À¯Çüº°(2020-2034³â)
    • À¯·´ : µî±Þº°(2020-2034³â)
    • À¯·´ : ¿ëµµº°(2020-2034³â)
    • À¯·´ : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : À¯Çüº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : µî±Þº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿ëµµº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
    • Áß±¹
    • Àεµ
    • ¸»·¹À̽þÆ
    • ÀϺ»
    • Àεµ³×½Ã¾Æ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : À¯Çüº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : µî±Þº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿ëµµº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : À¯Çüº°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : µî±Þº°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¿ëµµº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
    • ¸ß½ÃÄÚ
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • »ç¾÷ È®´ë, ±â¾÷ Àμö ºÐ¼®
    • »ç¾÷ È®´ë
    • ±â¾÷ Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦11Àå ±â¾÷ °³¿ä

  • Catalent
  • Charles River Laboratories
  • Danaher
  • Elegen
  • Eurofins Genomics
  • GenScript
  • Kaneka Corp.
  • Lonza
  • ProBio
  • Thermo Fisher Scientific
  • Touchlight
  • VGXI, Inc.
  • Wuxi AppTec
LSH

The dna manufacturing market size is expected to reach USD 21.82 billion by 2034, according to a new study by Polaris Market Research. The report "DNA Manufacturing Market Size, Share, Trends, & Industry Analysis Report By Type (Plasmid DNA, Synthetic DNA), By Grade, By Application, End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

DNA manufacturing, also known as synthetic biology or gene synthesis, is the process of artificially creating DNA molecules in a laboratory. Scientists design and assemble custom DNA sequences using advanced technologies, enabling them to produce genetic material that does not naturally exist or replicate existing sequences for research purposes. DNA manufacturing combines biology, chemistry, and engineering to build precise genetic constructs, creating the way for innovations in medicine, agriculture, and biotechnology.

One of the primary uses of DNA manufacturing is in medical research and drug development. Scientists synthesize genes to study diseases, create vaccines, and develop gene therapies. For instance, synthetic DNA helps produce mRNA vaccines and therapeutics, such as those used against COVID-19, by providing the genetic blueprint for an immune response. Additionally, researchers develop microbes with synthetic DNA to manufacture insulin, antibodies, and other life-saving biologics more efficiently than traditional methods.

The growing demand for personalized medicine is driving the DNA manufacturing market growth. DNA manufacturing enables scientists to design custom genetic sequences that help create personalized treatments, such as gene therapies for rare genetic disorders or cancer immunotherapies that target specific mutations.

DNA Manufacturing Market Report Highlights

In terms of type, the synthetic DNA segment accounted for a major market share in 2024 due to its widespread applications in therapeutics, diagnostics, and synthetic biology.

Based on grade, the GMP grade segment held a larger market share in 2024 due to rising demand for clinical-grade DNA used in advanced therapeutic applications such as gene therapy, cell therapy, and DNA-based vaccines.

In terms of application, the cell & gene therapy segment dominated the revenue market share in 2024. This dominance is attributed to the rapid expansion of clinical and commercial activity in advanced therapeutic platforms.

Based on end use, the contract research organizations segment is projected to grow at a robust pace in the coming years. CROs offer specialized expertise, scalable manufacturing, and faster turnaround times, making them essential partners for drug development.

The North America DNA manufacturing market accounted for 47.38% of global revenue share in 2024. This dominance is attributed to advancements in biotechnology, pharmaceuticals, and synthetic biology.

The DNA manufacturing industry in Asia Pacific is projected to grow at a robust pace in the coming years, owing to expanding biopharmaceutical sectors, increasing R&D investments, and government support for genomics.

A few global key market players include Catalent; Charles River Laboratories; Danaher; Elegen; Eurofins Genomics; GenScript; Kaneka Corp.; Lonza; ProBio; Thermo Fisher Scientific; Touchlight; VGXI, Inc.; and Wuxi AppTec.

Polaris Market Research has segmented the DNA manufacturing market report on the basis of type, grade, application, end use, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Plasmid DNA

Synthetic DNA

Gene Synthesis

Oligonucleotide Synthesis

By Grade Outlook (Revenue, USD Billion, 2020-2034)

GMP Grade

R&D Grade

By Application Outlook (Revenue, USD Billion, 2020-2034)

Cell & Gene Therapy

Vaccines

Oligonucleotide-Based drugs

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical and Biotechnology Companies

Academic & Research Institutes

Contract Research Organizations

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global DNA Manufacturing Market Insights

  • 4.1. DNA Manufacturing Market - Market Snapshot
  • 4.2. DNA Manufacturing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing demand for gene therapies
      • 4.2.1.2. Rising demand for personalized medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Strict Regulation Norms
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. DNA Manufacturing Market Trends
  • 4.6. Value Chain Analysis

5. Global DNA Manufacturing Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Plasmid DNA
    • 5.3.1. Global DNA Manufacturing Market, by Plasmid DNA, by Region, 2020-2034 (USD Billion)
  • 5.4. Synthetic DNA
    • 5.4.1. Global DNA Manufacturing Market, by Synthetic DNA, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Gene Synthesis
      • 5.4.2.1. Global DNA Manufacturing Market, by Gene Synthesis, by Region, 2020-2034 (USD Billion)
    • 5.4.3. Oligonucleotide Synthesis
      • 5.4.3.1. Global DNA Manufacturing Market, by Oligonucleotide Synthesis, by Region, 2020-2034 (USD Billion)

6. Global DNA Manufacturing Market, by Grade

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
  • 6.3. GMP Grade
    • 6.3.1. Global DNA Manufacturing Market, by GMP Grade, by Region, 2020-2034 (USD Billion)
  • 6.4. R&D Grade
    • 6.4.1. Global DNA Manufacturing Market, by R&D Grade, by Region, 2020-2034 (USD Billion)

7. Global DNA Manufacturing Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
  • 7.3. Cell & Gene Therapy
    • 7.3.1. Global DNA Manufacturing Market, by Cell & Gene Therapy, by Region, 2020-2034 (USD Billion)
  • 7.4. Vaccines
    • 7.4.1. Global DNA Manufacturing Market, by Vaccines, by Region, 2020-2034 (USD Billion)
  • 7.5. Oligonucleotide-based drugs
    • 7.5.1. Global DNA Manufacturing Market, by Oligonucleotide-based drugs, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global DNA Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global DNA Manufacturing Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
  • 8.3. Pharmaceutical and Biotechnology Companies
    • 8.3.1. Global DNA Manufacturing Market, by Pharmaceutical and Biotechnology Companies, by Region, 2020-2034 (USD Billion)
  • 8.4. Academic & Research Institutes
    • 8.4.1. Global DNA Manufacturing Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Billion)
  • 8.5. Contract Research Organizations
    • 8.5.1. Global DNA Manufacturing Market, by Contract Research Organizations, by Region, 2020-2034 (USD Billion)

9. Global DNA Manufacturing Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. DNA Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. DNA Manufacturing Market - North America
    • 9.3.1. North America: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
    • 9.3.2. North America: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
    • 9.3.3. North America: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
    • 9.3.4. North America: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.5. DNA Manufacturing Market - US
      • 9.3.5.1. US: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.3.5.2. US: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.3.5.3. US: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.3.5.4. US: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.6. DNA Manufacturing Market - Canada
      • 9.3.6.1. Canada: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
  • 9.4. DNA Manufacturing Market - Europe
    • 9.4.1. Europe: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
    • 9.4.2. Europe: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
    • 9.4.3. Europe: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
    • 9.4.4. Europe: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.5. DNA Manufacturing Market - UK
      • 9.4.5.1. UK: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.6. DNA Manufacturing Market - France
      • 9.4.6.1. France: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.6.2. France: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.4.6.3. France: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.4.6.4. France: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.7. DNA Manufacturing Market - Germany
      • 9.4.7.1. Germany: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.8. DNA Manufacturing Market - Italy
      • 9.4.8.1. Italy: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.9. DNA Manufacturing Market - Spain
      • 9.4.9.1. Spain: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.10. DNA Manufacturing Market - Netherlands
      • 9.4.10.1. Netherlands: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.11. DNA Manufacturing Market - Russia
      • 9.4.11.1. Russia: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.12. DNA Manufacturing Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
  • 9.5. DNA Manufacturing Market - Asia Pacific
    • 9.5.1. Asia Pacific: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.5. DNA Manufacturing Market - China
      • 9.5.5.1. China: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.5.2. China: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.5.5.3. China: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.5.5.4. China: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.6. DNA Manufacturing Market - India
      • 9.5.6.1. India: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.6.2. India: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.5.6.3. India: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.5.6.4. India: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.7. DNA Manufacturing Market - Malaysia
      • 9.5.7.1. Malaysia: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.8. DNA Manufacturing Market - Japan
      • 9.5.8.1. Japan: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.9. DNA Manufacturing Market - Indonesia
      • 9.5.9.1. Indonesia: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.10. DNA Manufacturing Market - South Korea
      • 9.5.10.1. South Korea: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.11. DNA Manufacturing Market - Australia
      • 9.5.11.1. Australia: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.12. DNA Manufacturing Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
  • 9.6. DNA Manufacturing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.5. DNA Manufacturing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.6. DNA Manufacturing Market - UAE
      • 9.6.6.1. UAE: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.7. DNA Manufacturing Market - Israel
      • 9.6.7.1. Israel: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.8. DNA Manufacturing Market - South Africa
      • 9.6.8.1. South Africa: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.9. DNA Manufacturing Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
  • 9.7. DNA Manufacturing Market - Latin America
    • 9.7.1. Latin America: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.5. DNA Manufacturing Market - Mexico
      • 9.7.5.1. Mexico: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.6. DNA Manufacturing Market - Brazil
      • 9.7.6.1. Brazil: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.7. DNA Manufacturing Market - Argentina
      • 9.7.7.1. Argentina: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.8. DNA Manufacturing Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Catalent
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Charles River Laboratories
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Danaher
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Elegen
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Eurofins Genomics
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. GenScript
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Kaneka Corp.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
  • 11.8. Lonza
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. ProBio
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Thermo Fisher Scientific
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Touchlight
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. VGXI, Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Wuxi AppTec
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦